OGEDA
ActiveSummary
OGEDA has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €53.3m and a net result of €5.2m. Equity is shrinking by ~32.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 266 sector peers (NACE 72, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Owners and capital
Owners
1 ownerChain of control
- Astellas Pharma IncJP
- OGEDA
Highest known parent: Astellas Pharma Inc (Japan). The sources do not say who stands above it.
Owners 1
- Astellas Pharma IncJPconsolidating parentconsolidates
According to the annual accounts of the companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.